BMC offers a number of clinical trials specifically for multiple myeloma patients. Promising new techniques in the diagnosis, treatment, and care of patients with cancer are tested in these studies. The number and types of clinical trials available are constantly changing. View an up-to-date list of ongoing trials here.
The Multiple Myeloma Program conducts clinical trials sponsored by many sources. The program’s affiliation with the National Cancer Institute (NCI) trials coordinated through SWOG and NRG Oncology allow patients access to some of the newest treatment options available.
Those interested in participating in any clinical trials at BMC, should talk with their physician.